Pharmaceutical Liability

Pharmaceutical liability refers to legal theories andcontrols used to maintain the drug's quality are
ways to prove that the manufacturer of aadequate to preserve the drug's identity, strength,
prescription drug, over-the-counter medication,quality, and purity.
dietary supplement or herbal remedy may beThe NDA documents the drug's history including what
responsible when the drug causes injury or death.happened during the clinical tests, what the
The Food and Drug Administration ("FDA") is theingredients of the drug are, the results of the animal
government agency that is responsible for ensuringstudies, how the drug behaves in the body, and how
that our drug supply is safe and effective. Approvalit is manufactured, processed and packaged. After
of prescription drugs is the job of the FDA's Centerthe FDA approves a drug for a particular use,
for Drug Evaluation and Research ("CDER").patients who are injured by the drug must look to
Since 1938, every new drug has been the subject ofthe manufacturer for redress, whether the drug is
an approved New Drug Application ("NDA") beforeused for its approved purpose or for some other
U.S. commercialization. The NDA is the mechanism byreason (known as "off-label" use). Manufacturers will
which drug sponsors formally propose to the FDAsometimes try to persuade a jury that, because the
that the FDA approve a new pharmaceutical for saleFDA approved the medication, the manufacturer
and marketing in the U.S. The data gathered duringshould not be liable for any injuries the medication
the animal studies and human clinical trials of ancaused, particularly in cases of "off-label" use.
Investigational New Drug become part of the NDA.In some instances, a company discovers that one of
The FDA reviews the medication and may approve itits products is defective and has the potential to
for sale, but the FDA does not guarantee drugcause injury, pain or death. The company may recall
safety.the drug entirely on its own. In others instances, the
The purpose of the NDA is to provide enoughFDA informs a company of findings that one of its
information to permit the FDA reviewer to reach theproducts is defective and suggests or requests a
following key decisions:o Whether the drug is saferecall. Usually, the company will comply. If the firm
and effective in its proposed use(s), and whether thedoes not recall the product, then FDA can seek legal
benefits of the drug outweigh the risks.o Whetheraction. FDA actions may include seizure of the
the drug's proposed labeling or package insert isavailable drug, and/or an injunction against the firm,
appropriate, and what it should contain.o Whether theand a court order for recall of the product.
methods used to manufacture the drug and the